scholarly journals Ulcerative Colitis Developed in a COVID-19 Patient: A Case Report

2020 ◽  
Author(s):  
Muhammet Fatih Aydin ◽  
Hamit Tasdemir
Keyword(s):  
Ulcerative Colitis ◽  
Respiratory Symptoms ◽  
Viral Disease ◽  
Gastrointestinal System ◽  
World Health ◽  
Case Presentation ◽  
The World ◽  
Bowel Diseases ◽  
Inflammatory Bowel ◽  
Health Organization

Abstract Background: COVID-19 pneumonia is a widespread viral disease, which affects all the world and has been accepted as pandemic by the World Health Organization (WHO). Coronavirus can remain in the stool for certain time even after recovery from COVID-19 pneumonia in some infected patients. Studies increasingly report involvement of other organs including gastrointestinal system in addition to respiratory symptoms in COVID-19. Ulcerative colitis is an inflammatory bowel disease with unknown cause. Emerging data suggest that gastrointestinal system may also be influenced by COVID-19 based via the expression of ACE-2. However, data abour the association of COVID-19 and inflammatory bowel diseases including ulcerative colitis are lacking. Case Presentation: In this report, we present a case of ulcerative colitis diagnosed in a 50-year-old male patient who presented with the complaints of bloody diarrhea and abdominal pain following the completion of the treatment of COVID-19 pneumonia. Conclusion: Patients presenting with gastrointestnal complaints should also be evaluated for COVID-19.

scholarly journals Inflammatory bowel disease and COVID-19: A review

2021 ◽  
Vol 2 (5) ◽  
Author(s):  
Rabin Hamal ◽  
◽  
Rahul Pathak ◽  
Brindeswari Kafle Bhandari ◽  
Anurag Jha ◽  
...  
Keyword(s):  
Immunosuppressive Drugs ◽  
World Health ◽  
Noncommunicable Diseases ◽  
Severe Illness ◽  
Infectious Risk ◽  
The World ◽  
Bowel Diseases ◽  
Inflammatory Bowel ◽  
Health Organization ◽  
Chronic Inflammatory Bowel

The World Health Organization officially declared infection with severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), leading to coronavirus disease 2019 (COVID-19) as a Public Health Emergency of International Concern (PHEIC) on 30 January 2020 and then as a pandemic on March 11, 2020 with reports of infection from most of the countries of the world [1]. COVID-19 has severely disrupted prevention and treatment for noncommunicable diseases. Severe illness can occur in otherwise healthy individuals of any age, but it predominantly occurs in adults with advanced age or certain underlying medical comorbidities [2]. Since the beginning of the health emergency, particular attention has been paid to the management of patients with chronic Inflammatory Bowel Diseases (IBDs) because they frequently are treated with immunosuppressive drugs and therefore potentially are exposed to a greater infectious risk than the general population [3].

scholarly journals Inflammatory bowel disease and COVID-19: A review

2021 ◽  
Vol 1 (3) ◽  
Author(s):  
Rabin Hamal ◽  
◽  
Rahul Pathak ◽  
Brindeswari Kafle Bhandari ◽  
Anurag Jha; Arun Gnawali ◽  
...  
Keyword(s):  
Immunosuppressive Drugs ◽  
World Health ◽  
Noncommunicable Diseases ◽  
Severe Illness ◽  
Infectious Risk ◽  
The World ◽  
Bowel Diseases ◽  
Inflammatory Bowel ◽  
Health Organization ◽  
Chronic Inflammatory Bowel

The World Health Organization officially declared infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to coronavirus disease 2019 (COVID-19) as a Public Health Emergency of International Concern (PHEIC) on 30 January 2020 and then as a pandemic on March 11, 2020 with reports of infection from most of the countries of the world [1]. COVID-19 has severely disrupted prevention and treatment for noncommunicable diseases. Severe illness can occur in otherwise healthy individuals of any age, but it predominantly occurs in adults with advanced age or certain underlying medical comorbidities [2]. Since the beginning of the health emergency, particular attention has been paid to the management of patients with chronic Inflammatory Bowel Diseases (IBDs) because they frequently are treated with immunosuppressive drugs and therefore potentially are exposed to a greater infectious risk than the general population [3].

scholarly journals Post-COVID-19 Massive Hemoptysis and Gastrointestinal Bleeding: A Case Report

2021 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Gholamreza Soleimani ◽  
Saeedeh Yaghoubi ◽  
Elham Shafighi Shahri
Keyword(s):  
Respiratory Symptoms ◽  
Recovery Phase ◽  
World Health ◽  
Massive Hemoptysis ◽  
Gi Bleeding ◽  
Case Presentation ◽  
Global Epidemic ◽  
The World ◽  
Life Threatening ◽  
Health Organization

Introduction: COVID-19 is a new respiratory infection caused by the coronavirus, which the World Health Organization (WHO) declared as a global epidemic in 2019. All the information obtained about this virus was different in children than in adults. Case Presentation: The case investigated in this study was a 10-year-old boy with hemoptysis and gastrointestinal (GI) bleeding in his post-COVID-19 recovery phase. Conclusions: COVID-19 can have a variety of presentations and complications beyond the classic respiratory symptoms and fever. This case is important and shows how COVID-19 can be life-threatening.

scholarly journals Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine

2019 ◽  
Author(s):  
Petter I. Andersen ◽  
Klara Krpina ◽  
Aleksandr Ianevski ◽  
Nastassia Shtaida ◽  
Eunji Jo ◽  
...  
Keyword(s):  
Influenza A ◽  
Rift Valley Fever Virus ◽  
Antiviral Agents ◽  
Viral Disease ◽  
World Health ◽  
Valley Fever ◽  
The World ◽  
Health Organization ◽  
Hiv 1

Viruses are the major causes of acute and chronic infectious diseases in the world. According to the World Health Organization, there is an urgent need for better control of viral diseases. Re-purposing existing antiviral agents from one viral disease to another could play a pivotal role in this process. Here we identified novel activities of obatoclax and emetine against herpes simplex virus type 2 (HSV-2), human immunodeficiency virus 1 (HIV-1), echovirus 1 (EV1), human metapneumovirus (HMPV) and Rift Valley fever virus (RVFV) in cell cultures. Moreover, we demonstrated novel activities of emetine against influenza A virus (FluAV), niclosamide against HSV-2, brequinar against HIV-1, and homoharringtonine against EV1. Our findings may expand the spectrum of indications of these safe-in-man agents and reinforce the arsenal of available antiviral therapeutics pending the results of further in vivo tests.

scholarly journals The Central Role of Non-Structural Protein 1 (NS1) in Influenza Biology and Infection

2020 ◽  
Vol 21 (4) ◽  
pp. 1511 ◽  
Author(s):  
Nícia Rosário-Ferreira ◽  
António J. Preto ◽  
Rita Melo ◽  
Irina S. Moreira ◽  
Rui M. M. Brito
Keyword(s):  
Viral Disease ◽  
Influenza Viruses ◽  
World Health ◽  
World Population ◽  
Structural Protein ◽  
Human Respiratory Tract ◽  
Host Interactions ◽  
The World ◽  
Health Organization

Influenza (flu) is a contagious viral disease, which targets the human respiratory tract and spreads throughout the world each year. Every year, influenza infects around 10% of the world population and between 290,000 and 650,000 people die from it according to the World Health Organization (WHO). Influenza viruses belong to the Orthomyxoviridae family and have a negative sense eight-segment single-stranded RNA genome that encodes 11 different proteins. The only control over influenza seasonal epidemic outbreaks around the world are vaccines, annually updated according to viral strains in circulation, but, because of high rates of mutation and recurrent genetic assortment, new viral strains of influenza are constantly emerging, increasing the likelihood of pandemics. Vaccination effectiveness is limited, calling for new preventive and therapeutic approaches and a better understanding of the virus–host interactions. In particular, grasping the role of influenza non-structural protein 1 (NS1) and related known interactions in the host cell is pivotal to better understand the mechanisms of virus infection and replication, and thus propose more effective antiviral approaches. In this review, we assess the structure of NS1, its dynamics, and multiple functions and interactions, to highlight the central role of this protein in viral biology and its potential use as an effective therapeutic target to tackle seasonal and pandemic influenza.

scholarly journals Obstetrics and gynaecology in the era of COVID-19

2020 ◽  
Vol 9 (11) ◽  
pp. 4777
Author(s):  
Angela Mary George ◽  
Daniel Manoj ◽  
Sowmya Ramani ◽  
Lalropuii . ◽  
Murugan Timiri Palani ◽  
...  
Keyword(s):  
Women’S Health ◽  
Women's Health ◽  
Psychosocial Support ◽  
Viral Disease ◽  
World Health ◽  
Significant Morbidity ◽  
Obstetrics And Gynaecology ◽  
Global Pandemic ◽  
The World ◽  
Health Organization

The World Health Organization has declared the outbreak of COVID-19 as a global pandemic. The alarming levels of spread and severity of the viral disease has resulted in significant morbidity and mortality. Women often face the highest risk of suffering devastating losses from the pandemic. Historically, women’s health has always been inadequately represented in responses to global outbreaks. Resources are often funnelled away from women’s health services towards targets perceived to be more important. Pregnant women with suspected, probable or confirmed COVID-19, should have access to obstetric and foetal medicine, neonatal care as well as mental health and psychosocial support, at facilities ready to tackle maternal and neonatal complications. In this article, we attempt to look at the challenges faced by gynaecologists because of this pandemic, and provide an overview on the current protocols in antenatal care, foetal care, childbirth, and oncological care.

Can the Use of Bedside Lung Ultrasound Reduce Transmission Rates in The Case of The COVID-19 Patient? - A Narrative Review

POCUS Journal ◽  
2020 ◽  
Vol 5 (1) ◽  
pp. 26-28
Author(s):  
Sheena Bhimji-Hewitt MAppSc; DMS, CRGS, RDMS
Keyword(s):  
Health Care Workers ◽  
Lung Ultrasound ◽  
Virus Disease ◽  
Viral Disease ◽  
World Health ◽  
Rapid Review ◽  
Limited Information ◽  
Care Workers ◽  
The World ◽  
Health Organization

Novel Corona Virus Disease-19 (nCov-19, COVID-19) was recognised as a pandemic by the World Health Organization on March 11, 2020. As of June 14, 2020, this contagious viral disease has afflicted 188 out of 195 countries in the world with 7,893,700 confirmed cases and 432,922 global deaths. Canada has 98,787 people infected and 8,146 deaths. COVID-19 is thought to transmit through contact, droplets and aerosolization. A rapid review showed limited information on the benefits of conducting lung ultrasound (LUS) versus chest radiograph (CXR) or studies correlating lung ultrasound to chest computed Tomography (CT) in patients positive for Covid-19. The literature review confirmed that CT and LUS cannot diagnose this disease, but that both can help in the management and staging of this disease. There is no literature to prove that LUS at the bedside may be beneficial from the view of decreased transmission to other health care workers and bystanders due to reduced transit but comparing the transit pathway and contact leads one to propose that this would be so. Pregnant patients with COVID-19, young children and patients in the reproductive stage would also benefit from LUS since there is no radiation dose and the critical patient in distress will benefit from testing at the bedside.

scholarly journals A fatal case of chlorfenapyr poisoning following dermal exposure

2018 ◽  
Vol 26 (6) ◽  
pp. 375-378
Author(s):  
Sang-Kyoon Han ◽  
Seok-Ran Yeom ◽  
Sung-Hwa Lee ◽  
Soon-Chang Park ◽  
Hyung-Bin Kim ◽  
...  
Keyword(s):  
World Health Organization ◽  
Fatal Case ◽  
Dermal Absorption ◽  
World Health ◽  
Oral Ingestion ◽  
Case Presentation ◽  
Skin Exposure ◽  
The World ◽  
Main Activity ◽  
Health Organization

Introduction: Chlorfenapyr is a pyrrole-based pro-insecticide. The main activity of this agent is the inhibition of adenosine triphosphate synthesis, and it is used in agriculture to control several insects and mites resistant to carbamate, organophosphate and pyrethroid insecticide. The World Health Organization classifies this agent as a class II toxin (moderately hazardous). Case presentation: All previously reported cases of chlorfenapyr poisoning in humans occurred following oral ingestion except one case involving exposure to chlorfenapyr vapour. Discussion: In this report, we describe a case of chlorfenapyr intoxication after skin exposure in a 49-year-old patient who died 5 days after exposure. Conclusion: This case demonstrates that similar to oral ingestion, dermal absorption of chlorfenapyr may also be fatal.

scholarly journals The 2019 measles epidemic in Bosnia and Herzegovina: What is wrong with the mandatory vaccination program?

2019 ◽  
Author(s):  
Jurica Arapović ◽  
Željana Sulaver ◽  
Borko Rajič ◽  
Aida Pilav
Keyword(s):  
Bosnia And Herzegovina ◽  
Transmission Rate ◽  
Viral Disease ◽  
World Health ◽  
Vaccination Program ◽  
Key Stakeholders ◽  
The World ◽  
Health Organization ◽  
Mandatory Vaccination ◽  
Endemic Transmission

Measles are a highly contagious and communicable viral disease which may be prevented by a sustained vaccination program. Due to missed vaccination, two major epidemics of measles (1997–1999 and 2014–2015) have been recorded after the war in Bosnia and Herzegovina (BH) with over 10,000 patients registered. According to the World Health Organization, BH is categorized as a country with endemic transmission of measles. The last measles epidemic was between 2014 and 2015, with 5,083 documented patients in the Federation of BH. In the first four months of 2019, more than 700 measles cases were registered in the same region. Significant transmission rate has been observed in Sarajevo Canton (SC) with 570 documented measles cases. Out of 570 measles cases in SC, 92.5% were unvaccinated. The most affected were children up to 6 years of age (62.8%), with one documented case of death (7-month old infant). In addition to this report, we discussed key stakeholders and possible circumstances responsible for the epidemic. The measles epidemic is still ongoing.

scholarly journals Prospects for application of physical exercises and phytotherapy in patients with ulcerative colitis

2020 ◽  
pp. 22-24
Author(s):  
V. A. Akhmedov ◽  
T. I. Melikov
Keyword(s):  
Ulcerative Colitis ◽  
Physical Inactivity ◽  
Dietary Habits ◽  
Developed Countries ◽  
Physical Exercises ◽  
The World ◽  
Bowel Diseases ◽  
Inflammatory Bowel ◽  
The Developed Countries ◽  
Methods Of Treatment

The incidence and prevalence of inflammatory bowel diseases rapidly increased in last years in developed countries and the rise witnessed in the rest of the world closely correlates with adopting a western lifestyle. These observations support the notion that a variety of environmental factors contribute to the pathogenesis of intestinal diseases. In the developed countries, peoples’ lifestyle has changed significantly, being affected by serious modifications in dietary habits and physical inactivity. Those changes in lifestyle may have a bearing on the course of the disease and require correction with the use of physical exercises and other non-drug methods of treatment.

Sign in / Sign up

Export Citation Format

Share Document